Dhaka, July 27 -- Fosun Hospital Guangzhou, a member of Fosun Health, has completed the cell collection procedure for the first gastric cancer patient receiving treatment with Kailimei(R) (Satricabtagene Autoleucel Injection, R&D code: CT041) therapy pathway in the Greater Bay Area.

Professor Chen Tao, Director of the International Medical Center at Fosun Hospital Guangzhou, stated that the completion of this first patient cell collection marks the official initiation of standardized clinical application of the world's first approved solid tumor CAR-T cell therapy product at Fosun Health, providing a new treatment option for eligible patients with advanced gastrointestinal cancers.

Cell collection represents the critical first step in t...